Literature DB >> 15924347

Surface roughness contribution to the adhesion force distribution of salmeterol xinafoate on lactose carriers by atomic force microscopy.

Nazrul Islam1, Peter Stewart, Ian Larson, Patrick Hartley.   

Abstract

Adhesion force distributions of silica spheres (5 and 20 microm) and salmeterol xinafoate (4 microm) particles with inhalation grade lactose surfaces and spin coated lactose films were determined by atomic force microscopy (AFM) to investigate the influence of surface roughness on the force distributions. The roughness of lactose particles and films was determined by both AFM and confocal microscopy (CM); the lactose particles showed RMS R(q) values between 0.93 and 2.2 microm. The adhesion force distributions for silica and SX probes were significantly different for the different lactose carriers and broad, e.g., the adhesion force distribution between a 5 microm silica sphere and lactose particles ranged from 5 to 105 nN. This contrasted with distributions on smooth spin coated lactose films (RMS R(q) of 0.28 nm) which were not significantly different and were narrow, e.g., the adhesion force distribution between a 5 microm silica sphere and spin coated lactose films was between 42 and 68 nN. In addition, no significant difference in adhesion force distribution occurred with silica probe size on the lactose carrier surface. The use of X-ray photoelectron spectroscopic analysis confirmed that the lactose surfaces were free of impurities that might contribute to variation in adhesion. Although the almost atomically flat films showed some adhesion variability, the surface roughness of the lactose particles was a major contributing factor to the broad distributions seen in this study. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15924347     DOI: 10.1002/jps.20381

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers.

Authors:  Jagdeep Shur; Bhawana Saluja; Sau Lee; James Tibbatts; Robert Price
Journal:  AAPS J       Date:  2015-05-09       Impact factor: 4.009

2.  The role of fines in the modification of the fluidization and dispersion mechanism within dry powder inhaler formulations.

Authors:  Jagdeep Shur; Haggis Harris; Matthew D Jones; J Sebastian Kaerger; Robert Price
Journal:  Pharm Res       Date:  2008-02-01       Impact factor: 4.200

3.  The contribution of different formulation components on the aerosol charge in carrier-based dry powder inhaler systems.

Authors:  Susan Hoe; Daniela Traini; Hak-Kim Chan; Paul M Young
Journal:  Pharm Res       Date:  2010-03-31       Impact factor: 4.200

4.  Evaluation of granulated lactose as a carrier for DPI formulations 1: effect of granule size.

Authors:  Ping Du; Ju Du; Hugh D C Smyth
Journal:  AAPS PharmSciTech       Date:  2014-06-25       Impact factor: 3.246

5.  Studies on the effect of the size of polycaprolactone microspheres for the dispersion of salbutamol sulfate from dry powder inhaler formulations.

Authors:  Rinku A Tuli; Graeme A George; Tim R Dargaville; Nazrul Islam
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

Review 6.  Inhaled antibiotic-loaded polymeric nanoparticles for the management of lower respiratory tract infections.

Authors:  Mohammad Zaidur Rahman Sabuj; Nazrul Islam
Journal:  Nanoscale Adv       Date:  2021-05-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.